nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—psoriasis—rheumatoid arthritis	0.876	1	CtDrD
Tazarotene—RXRB—Vitamin D Metabolism—GC—rheumatoid arthritis	0.00461	0.0833	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—MED1—rheumatoid arthritis	0.00204	0.0367	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—MED1—rheumatoid arthritis	0.00183	0.033	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—MED1—rheumatoid arthritis	0.00175	0.0316	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—MED1—rheumatoid arthritis	0.00175	0.0316	CbGpPWpGaD
Tazarotene—Application site irritation—Hydrocortisone—rheumatoid arthritis	0.00173	0.0263	CcSEcCtD
Tazarotene—Localized exfoliation—Triamcinolone—rheumatoid arthritis	0.00167	0.0255	CcSEcCtD
Tazarotene—RXRB—Vitamin D Metabolism—VDR—rheumatoid arthritis	0.00165	0.0298	CbGpPWpGaD
Tazarotene—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.00131	0.39	CbGbCtD
Tazarotene—CYP2C8—Cyclosporine—rheumatoid arthritis	0.00124	0.368	CbGbCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.00119	0.0214	CbGpPWpGaD
Tazarotene—Leukoderma—Prednisolone—rheumatoid arthritis	0.00115	0.0176	CcSEcCtD
Tazarotene—Leukoderma—Hydrocortisone—rheumatoid arthritis	0.00113	0.0172	CcSEcCtD
Tazarotene—Skin irritation—Hydrocortisone—rheumatoid arthritis	0.00111	0.0169	CcSEcCtD
Tazarotene—Application site pain—Hydrocortisone—rheumatoid arthritis	0.00109	0.0166	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.00107	0.0192	CbGpPWpGaD
Tazarotene—Leukoderma—Triamcinolone—rheumatoid arthritis	0.00106	0.0162	CcSEcCtD
Tazarotene—Leukoderma—Methylprednisolone—rheumatoid arthritis	0.00106	0.0161	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.00102	0.0184	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.00102	0.0184	CbGpPWpGaD
Tazarotene—Leukoderma—Betamethasone—rheumatoid arthritis	0.000963	0.0147	CcSEcCtD
Tazarotene—Leukoderma—Dexamethasone—rheumatoid arthritis	0.000963	0.0147	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Cyclosporine—rheumatoid arthritis	0.000939	0.0143	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—rheumatoid arthritis	0.000894	0.0161	CbGpPWpGaD
Tazarotene—Leukoderma—Prednisone—rheumatoid arthritis	0.000838	0.0128	CcSEcCtD
Tazarotene—Acne—Leflunomide—rheumatoid arthritis	0.00083	0.0127	CcSEcCtD
Tazarotene—Blood triglycerides increased—Cyclosporine—rheumatoid arthritis	0.000823	0.0125	CcSEcCtD
Tazarotene—CYP2C8—Dexamethasone—rheumatoid arthritis	0.000814	0.242	CbGbCtD
Tazarotene—Skin hyperpigmentation—Hydrocortisone—rheumatoid arthritis	0.000805	0.0123	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—VDR—rheumatoid arthritis	0.000802	0.0145	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—VDR—rheumatoid arthritis	0.000797	0.0144	CbGpPWpGaD
Tazarotene—Burning sensation—Cyclosporine—rheumatoid arthritis	0.000776	0.0118	CcSEcCtD
Tazarotene—Skin discolouration—Leflunomide—rheumatoid arthritis	0.000773	0.0118	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—rheumatoid arthritis	0.000769	0.0139	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—rheumatoid arthritis	0.000769	0.0139	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Triamcinolone—rheumatoid arthritis	0.000758	0.0116	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methylprednisolone—rheumatoid arthritis	0.000757	0.0115	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—REL—rheumatoid arthritis	0.000739	0.0133	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000721	0.013	CbGpPWpGaD
Tazarotene—Inflammation—Leflunomide—rheumatoid arthritis	0.00072	0.011	CcSEcCtD
Tazarotene—Haemoglobin—Penicillamine—rheumatoid arthritis	0.000717	0.0109	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—VDR—rheumatoid arthritis	0.000715	0.0129	CbGpPWpGaD
Tazarotene—Haemorrhage—Penicillamine—rheumatoid arthritis	0.000714	0.0109	CcSEcCtD
Tazarotene—Leukoderma—Methotrexate—rheumatoid arthritis	0.000701	0.0107	CcSEcCtD
Tazarotene—RARA—Adipogenesis—RETN—rheumatoid arthritis	0.000697	0.0126	CbGpPWpGaD
Tazarotene—Dermatitis contact—Leflunomide—rheumatoid arthritis	0.00069	0.0105	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Dexamethasone—rheumatoid arthritis	0.000688	0.0105	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Betamethasone—rheumatoid arthritis	0.000688	0.0105	CcSEcCtD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—VDR—rheumatoid arthritis	0.000685	0.0124	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—rheumatoid arthritis	0.000685	0.0124	CbGpPWpGaD
Tazarotene—Blister—Prednisolone—rheumatoid arthritis	0.000681	0.0104	CcSEcCtD
Tazarotene—Stinging—Cyclosporine—rheumatoid arthritis	0.000665	0.0101	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—VDR—rheumatoid arthritis	0.00066	0.0119	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000647	0.0117	CbGpPWpGaD
Tazarotene—Acne—Cyclosporine—rheumatoid arthritis	0.000641	0.00976	CcSEcCtD
Tazarotene—Blister—Triamcinolone—rheumatoid arthritis	0.000626	0.00954	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Prednisone—rheumatoid arthritis	0.000621	0.00946	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.00062	0.0112	CbGpPWpGaD
Tazarotene—Stinging—Prednisolone—rheumatoid arthritis	0.000605	0.00923	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—NR3C1—rheumatoid arthritis	0.000594	0.0107	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—VDR—rheumatoid arthritis	0.000592	0.0107	CbGpPWpGaD
Tazarotene—Stinging—Hydrocortisone—rheumatoid arthritis	0.000591	0.00901	CcSEcCtD
Tazarotene—Acne—Prednisolone—rheumatoid arthritis	0.000583	0.00888	CcSEcCtD
Tazarotene—Pain—Ergocalciferol—rheumatoid arthritis	0.000576	0.00878	CcSEcCtD
Tazarotene—Acne—Hydrocortisone—rheumatoid arthritis	0.000569	0.00868	CcSEcCtD
Tazarotene—Blister—Dexamethasone—rheumatoid arthritis	0.000568	0.00865	CcSEcCtD
Tazarotene—Blister—Betamethasone—rheumatoid arthritis	0.000568	0.00865	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors—VDR—rheumatoid arthritis	0.000567	0.0102	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—VDR—rheumatoid arthritis	0.000567	0.0102	CbGpPWpGaD
Tazarotene—Eczema—Leflunomide—rheumatoid arthritis	0.000564	0.0086	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.000564	0.0102	CbGpPWpGaD
Tazarotene—Stinging—Triamcinolone—rheumatoid arthritis	0.000557	0.00849	CcSEcCtD
Tazarotene—Blood triglycerides increased—Prednisone—rheumatoid arthritis	0.000544	0.00829	CcSEcCtD
Tazarotene—Acne—Triamcinolone—rheumatoid arthritis	0.000536	0.00817	CcSEcCtD
Tazarotene—Acne—Methylprednisolone—rheumatoid arthritis	0.000535	0.00815	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—NR3C1—rheumatoid arthritis	0.000533	0.00961	CbGpPWpGaD
Tazarotene—Skin discolouration—Hydrocortisone—rheumatoid arthritis	0.00053	0.00808	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—VDR—rheumatoid arthritis	0.000521	0.00941	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR3C1—rheumatoid arthritis	0.000511	0.00921	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR3C1—rheumatoid arthritis	0.000511	0.00921	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—MIF—rheumatoid arthritis	0.000509	0.00918	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.000506	0.00912	CbGpPWpGaD
Tazarotene—Stinging—Betamethasone—rheumatoid arthritis	0.000505	0.0077	CcSEcCtD
Tazarotene—Stinging—Dexamethasone—rheumatoid arthritis	0.000505	0.0077	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methotrexate—rheumatoid arthritis	0.000501	0.00763	CcSEcCtD
Tazarotene—Inflammation—Hydrocortisone—rheumatoid arthritis	0.000494	0.00753	CcSEcCtD
Tazarotene—Acne—Dexamethasone—rheumatoid arthritis	0.000486	0.00741	CcSEcCtD
Tazarotene—Acne—Betamethasone—rheumatoid arthritis	0.000486	0.00741	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—IL1A—rheumatoid arthritis	0.000485	0.00875	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.000485	0.00874	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.000485	0.00874	CbGpPWpGaD
Tazarotene—Dermatitis contact—Hydrocortisone—rheumatoid arthritis	0.000473	0.00722	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR3C1—rheumatoid arthritis	0.000469	0.00847	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—VDR—rheumatoid arthritis	0.000468	0.00844	CbGpPWpGaD
Tazarotene—Dry skin—Leflunomide—rheumatoid arthritis	0.000465	0.00708	CcSEcCtD
Tazarotene—Inflammation—Methylprednisolone—rheumatoid arthritis	0.000464	0.00707	CcSEcCtD
Tazarotene—Skin exfoliation—Hydrocortisone—rheumatoid arthritis	0.000457	0.00697	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—VDR—rheumatoid arthritis	0.000448	0.00809	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—VDR—rheumatoid arthritis	0.000448	0.00809	CbGpPWpGaD
Tazarotene—Dermatitis contact—Triamcinolone—rheumatoid arthritis	0.000446	0.00679	CcSEcCtD
Tazarotene—Eczema—Cyclosporine—rheumatoid arthritis	0.000435	0.00664	CcSEcCtD
Tazarotene—Skin exfoliation—Triamcinolone—rheumatoid arthritis	0.000431	0.00656	CcSEcCtD
Tazarotene—Skin exfoliation—Methylprednisolone—rheumatoid arthritis	0.00043	0.00655	CcSEcCtD
Tazarotene—Burning sensation—Methotrexate—rheumatoid arthritis	0.000429	0.00654	CcSEcCtD
Tazarotene—Acne—Prednisone—rheumatoid arthritis	0.000424	0.00646	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR3C1—rheumatoid arthritis	0.000421	0.00759	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Cyclosporine—rheumatoid arthritis	0.000409	0.00624	CcSEcCtD
Tazarotene—Dermatitis contact—Betamethasone—rheumatoid arthritis	0.000405	0.00617	CcSEcCtD
Tazarotene—Dermatitis contact—Dexamethasone—rheumatoid arthritis	0.000405	0.00617	CcSEcCtD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR3C1—rheumatoid arthritis	0.000404	0.00728	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—rheumatoid arthritis	0.000404	0.00728	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—rheumatoid arthritis	0.000391	0.00706	CbGpPWpGaD
Tazarotene—Skin exfoliation—Dexamethasone—rheumatoid arthritis	0.000391	0.00596	CcSEcCtD
Tazarotene—Skin exfoliation—Betamethasone—rheumatoid arthritis	0.000391	0.00596	CcSEcCtD
Tazarotene—Pruritus—Auranofin—rheumatoid arthritis	0.000388	0.00592	CcSEcCtD
Tazarotene—Eczema—Hydrocortisone—rheumatoid arthritis	0.000387	0.0059	CcSEcCtD
Tazarotene—RARA—Adipogenesis—AHR—rheumatoid arthritis	0.000382	0.00689	CbGpPWpGaD
Tazarotene—Haemoglobin—Azathioprine—rheumatoid arthritis	0.000373	0.00569	CcSEcCtD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK8—rheumatoid arthritis	0.000373	0.00673	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Prednisolone—rheumatoid arthritis	0.000373	0.00568	CcSEcCtD
Tazarotene—Haemorrhage—Azathioprine—rheumatoid arthritis	0.000371	0.00566	CcSEcCtD
Tazarotene—Dry skin—Cyclosporine—rheumatoid arthritis	0.000359	0.00547	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—rheumatoid arthritis	0.000354	0.00639	CbGpPWpGaD
Tazarotene—Haemoglobin—Leflunomide—rheumatoid arthritis	0.000353	0.00537	CcSEcCtD
Tazarotene—Haemorrhage—Leflunomide—rheumatoid arthritis	0.000351	0.00535	CcSEcCtD
Tazarotene—Rash—Auranofin—rheumatoid arthritis	0.000346	0.00527	CcSEcCtD
Tazarotene—Dermatitis—Auranofin—rheumatoid arthritis	0.000346	0.00527	CcSEcCtD
Tazarotene—Oedema peripheral—Leflunomide—rheumatoid arthritis	0.000346	0.00527	CcSEcCtD
Tazarotene—Dermatitis bullous—Triamcinolone—rheumatoid arthritis	0.000343	0.00522	CcSEcCtD
Tazarotene—Skin exfoliation—Prednisone—rheumatoid arthritis	0.00034	0.00519	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK8—rheumatoid arthritis	0.000335	0.00603	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—rheumatoid arthritis	0.000331	0.00597	CbGpPWpGaD
Tazarotene—Skin discolouration—Methotrexate—rheumatoid arthritis	0.00033	0.00503	CcSEcCtD
Tazarotene—Dry skin—Prednisolone—rheumatoid arthritis	0.000326	0.00497	CcSEcCtD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK8—rheumatoid arthritis	0.000321	0.00579	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—rheumatoid arthritis	0.000321	0.00579	CbGpPWpGaD
Tazarotene—Rash—Penicillamine—rheumatoid arthritis	0.00032	0.00487	CcSEcCtD
Tazarotene—Dermatitis—Penicillamine—rheumatoid arthritis	0.000319	0.00487	CcSEcCtD
Tazarotene—Dry skin—Hydrocortisone—rheumatoid arthritis	0.000319	0.00486	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—rheumatoid arthritis	0.000318	0.00573	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Betamethasone—rheumatoid arthritis	0.000311	0.00474	CcSEcCtD
Tazarotene—Dermatitis bullous—Dexamethasone—rheumatoid arthritis	0.000311	0.00474	CcSEcCtD
Tazarotene—Inflammation—Methotrexate—rheumatoid arthritis	0.000307	0.00468	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—rheumatoid arthritis	0.000305	0.0055	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—rheumatoid arthritis	0.000305	0.0055	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	0.000304	0.00549	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—GATA3—rheumatoid arthritis	0.000298	0.00537	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—rheumatoid arthritis	0.000297	0.00535	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—rheumatoid arthritis	0.000285	0.00513	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—rheumatoid arthritis	0.000285	0.00513	CbGpPWpGaD
Tazarotene—Skin exfoliation—Methotrexate—rheumatoid arthritis	0.000284	0.00433	CcSEcCtD
Tazarotene—RARA—Adipogenesis—ADIPOQ—rheumatoid arthritis	0.000273	0.00493	CbGpPWpGaD
Tazarotene—Dry skin—Dexamethasone—rheumatoid arthritis	0.000272	0.00415	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—rheumatoid arthritis	0.000272	0.00415	CcSEcCtD
Tazarotene—Haemoglobin—Cyclosporine—rheumatoid arthritis	0.000272	0.00415	CcSEcCtD
Tazarotene—Discomfort—Azathioprine—rheumatoid arthritis	0.000272	0.00415	CcSEcCtD
Tazarotene—RARG—Gene Expression—ZNF184—rheumatoid arthritis	0.000271	0.0049	CbGpPWpGaD
Tazarotene—Haemorrhage—Cyclosporine—rheumatoid arthritis	0.000271	0.00413	CcSEcCtD
Tazarotene—Discomfort—Leflunomide—rheumatoid arthritis	0.000257	0.00391	CcSEcCtD
Tazarotene—Haemoglobin—Prednisolone—rheumatoid arthritis	0.000248	0.00377	CcSEcCtD
Tazarotene—Haemorrhage—Prednisolone—rheumatoid arthritis	0.000246	0.00375	CcSEcCtD
Tazarotene—RARA—Adipogenesis—STAT1—rheumatoid arthritis	0.000244	0.0044	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ZNF184—rheumatoid arthritis	0.000243	0.00439	CbGpPWpGaD
Tazarotene—Haemoglobin—Hydrocortisone—rheumatoid arthritis	0.000242	0.00369	CcSEcCtD
Tazarotene—Haemorrhage—Hydrocortisone—rheumatoid arthritis	0.000241	0.00367	CcSEcCtD
Tazarotene—Dry skin—Prednisone—rheumatoid arthritis	0.000237	0.00361	CcSEcCtD
Tazarotene—RXRB—Gene Expression—ZNF184—rheumatoid arthritis	0.000233	0.00421	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ZNF184—rheumatoid arthritis	0.000233	0.00421	CbGpPWpGaD
Tazarotene—Haemoglobin—Triamcinolone—rheumatoid arthritis	0.000228	0.00347	CcSEcCtD
Tazarotene—Haemoglobin—Methylprednisolone—rheumatoid arthritis	0.000227	0.00346	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—rheumatoid arthritis	0.000227	0.00345	CcSEcCtD
Tazarotene—Haemorrhage—Methylprednisolone—rheumatoid arthritis	0.000226	0.00344	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	0.000216	0.0039	CbGpPWpGaD
Tazarotene—Erythema—Prednisolone—rheumatoid arthritis	0.000214	0.00327	CcSEcCtD
Tazarotene—Pain—Leflunomide—rheumatoid arthritis	0.000213	0.00325	CcSEcCtD
Tazarotene—Erythema—Hydrocortisone—rheumatoid arthritis	0.000209	0.00319	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—rheumatoid arthritis	0.000207	0.00315	CcSEcCtD
Tazarotene—Haemoglobin—Betamethasone—rheumatoid arthritis	0.000207	0.00315	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	0.000206	0.00372	CbGpPWpGaD
Tazarotene—Haemorrhage—Dexamethasone—rheumatoid arthritis	0.000206	0.00313	CcSEcCtD
Tazarotene—Haemorrhage—Betamethasone—rheumatoid arthritis	0.000206	0.00313	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—MED1—rheumatoid arthritis	0.000205	0.0037	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—MAPK8—rheumatoid arthritis	0.000203	0.00367	CbGpPWpGaD
Tazarotene—Discomfort—Cyclosporine—rheumatoid arthritis	0.000198	0.00302	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	0.000198	0.00357	CbGpPWpGaD
Tazarotene—Erythema—Triamcinolone—rheumatoid arthritis	0.000197	0.00301	CcSEcCtD
Tazarotene—Erythema—Methylprednisolone—rheumatoid arthritis	0.000197	0.003	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	0.000194	0.0035	CbGpPWpGaD
Tazarotene—Oedema—Cyclosporine—rheumatoid arthritis	0.000192	0.00293	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000191	0.00345	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NR3C1—rheumatoid arthritis	0.000191	0.00344	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	0.000187	0.00338	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	0.000186	0.00335	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	0.000186	0.00335	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—FAS—rheumatoid arthritis	0.000185	0.00334	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MED1—rheumatoid arthritis	0.000184	0.00332	CbGpPWpGaD
Tazarotene—Discomfort—Prednisolone—rheumatoid arthritis	0.00018	0.00275	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—rheumatoid arthritis	0.00018	0.00274	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	0.000179	0.00324	CbGpPWpGaD
Tazarotene—Haemorrhage—Prednisone—rheumatoid arthritis	0.000179	0.00273	CcSEcCtD
Tazarotene—Erythema—Betamethasone—rheumatoid arthritis	0.000179	0.00273	CcSEcCtD
Tazarotene—Erythema—Dexamethasone—rheumatoid arthritis	0.000179	0.00273	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—MED1—rheumatoid arthritis	0.000176	0.00318	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MED1—rheumatoid arthritis	0.000176	0.00318	CbGpPWpGaD
Tazarotene—Pruritus—Leflunomide—rheumatoid arthritis	0.000176	0.00269	CcSEcCtD
Tazarotene—Discomfort—Hydrocortisone—rheumatoid arthritis	0.000176	0.00268	CcSEcCtD
Tazarotene—Oedema—Prednisolone—rheumatoid arthritis	0.000175	0.00267	CcSEcCtD
Tazarotene—Oedema—Hydrocortisone—rheumatoid arthritis	0.000171	0.00261	CcSEcCtD
Tazarotene—Photosensitivity reaction—Methotrexate—rheumatoid arthritis	0.000171	0.0026	CcSEcCtD
Tazarotene—RARA—Adipogenesis—LEP—rheumatoid arthritis	0.00017	0.00306	CbGpPWpGaD
Tazarotene—Rash—Azathioprine—rheumatoid arthritis	0.000166	0.00254	CcSEcCtD
Tazarotene—Dermatitis—Azathioprine—rheumatoid arthritis	0.000166	0.00253	CcSEcCtD
Tazarotene—Discomfort—Triamcinolone—rheumatoid arthritis	0.000166	0.00253	CcSEcCtD
Tazarotene—Discomfort—Methylprednisolone—rheumatoid arthritis	0.000166	0.00252	CcSEcCtD
Tazarotene—Pain—Cyclosporine—rheumatoid arthritis	0.000164	0.00251	CcSEcCtD
Tazarotene—Oedema—Triamcinolone—rheumatoid arthritis	0.000161	0.00245	CcSEcCtD
Tazarotene—RARA—Adipogenesis—IL6ST—rheumatoid arthritis	0.000159	0.00288	CbGpPWpGaD
Tazarotene—Rash—Leflunomide—rheumatoid arthritis	0.000157	0.00239	CcSEcCtD
Tazarotene—Dermatitis—Leflunomide—rheumatoid arthritis	0.000157	0.00239	CcSEcCtD
Tazarotene—RARG—Gene Expression—HNRNPA2B1—rheumatoid arthritis	0.000156	0.00281	CbGpPWpGaD
Tazarotene—Erythema—Prednisone—rheumatoid arthritis	0.000156	0.00237	CcSEcCtD
Tazarotene—Discomfort—Betamethasone—rheumatoid arthritis	0.000151	0.00229	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—rheumatoid arthritis	0.000151	0.00229	CcSEcCtD
Tazarotene—Haemoglobin—Methotrexate—rheumatoid arthritis	0.00015	0.00229	CcSEcCtD
Tazarotene—Pain—Prednisolone—rheumatoid arthritis	0.00015	0.00228	CcSEcCtD
Tazarotene—Haemorrhage—Methotrexate—rheumatoid arthritis	0.00015	0.00228	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	0.000147	0.00265	CbGpPWpGaD
Tazarotene—Pain—Hydrocortisone—rheumatoid arthritis	0.000146	0.00223	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—rheumatoid arthritis	0.000146	0.00223	CcSEcCtD
Tazarotene—Oedema—Betamethasone—rheumatoid arthritis	0.000146	0.00223	CcSEcCtD
Tazarotene—RARG—Gene Expression—DDX6—rheumatoid arthritis	0.000143	0.00257	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	0.000142	0.00256	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	0.000141	0.00254	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HNRNPA2B1—rheumatoid arthritis	0.00014	0.00252	CbGpPWpGaD
Tazarotene—Pain—Triamcinolone—rheumatoid arthritis	0.000138	0.0021	CcSEcCtD
Tazarotene—Pruritus—Cyclosporine—rheumatoid arthritis	0.000136	0.00207	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	0.000136	0.00245	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HNRNPA2B1—rheumatoid arthritis	0.000134	0.00242	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HNRNPA2B1—rheumatoid arthritis	0.000134	0.00242	CbGpPWpGaD
Tazarotene—Discomfort—Prednisone—rheumatoid arthritis	0.000131	0.002	CcSEcCtD
Tazarotene—Erythema—Methotrexate—rheumatoid arthritis	0.00013	0.00198	CcSEcCtD
Tazarotene—RARB—Gene Expression—DDX6—rheumatoid arthritis	0.000128	0.00231	CbGpPWpGaD
Tazarotene—Oedema—Prednisone—rheumatoid arthritis	0.000127	0.00194	CcSEcCtD
Tazarotene—Pain—Betamethasone—rheumatoid arthritis	0.000125	0.0019	CcSEcCtD
Tazarotene—Pain—Dexamethasone—rheumatoid arthritis	0.000125	0.0019	CcSEcCtD
Tazarotene—RARA—Gene Expression—DDX6—rheumatoid arthritis	0.000123	0.00221	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—DDX6—rheumatoid arthritis	0.000123	0.00221	CbGpPWpGaD
Tazarotene—Rash—Cyclosporine—rheumatoid arthritis	0.000121	0.00185	CcSEcCtD
Tazarotene—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000121	0.00185	CcSEcCtD
Tazarotene—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000121	0.00184	CcSEcCtD
Tazarotene—RARG—Gene Expression—ZFP36—rheumatoid arthritis	0.000118	0.00213	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	0.000118	0.00213	CbGpPWpGaD
Tazarotene—Pruritus—Triamcinolone—rheumatoid arthritis	0.000114	0.00174	CcSEcCtD
Tazarotene—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000114	0.00173	CcSEcCtD
Tazarotene—Rash—Prednisolone—rheumatoid arthritis	0.00011	0.00168	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—rheumatoid arthritis	0.00011	0.00168	CcSEcCtD
Tazarotene—Discomfort—Methotrexate—rheumatoid arthritis	0.00011	0.00167	CcSEcCtD
Tazarotene—Rash—Hydrocortisone—rheumatoid arthritis	0.000108	0.00164	CcSEcCtD
Tazarotene—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000108	0.00164	CcSEcCtD
Tazarotene—RARB—Gene Expression—ZFP36—rheumatoid arthritis	0.000106	0.00191	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	0.000106	0.00191	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RBPJ—rheumatoid arthritis	0.000104	0.00188	CbGpPWpGaD
Tazarotene—Pruritus—Dexamethasone—rheumatoid arthritis	0.000103	0.00157	CcSEcCtD
Tazarotene—Pruritus—Betamethasone—rheumatoid arthritis	0.000103	0.00157	CcSEcCtD
Tazarotene—RXRB—Gene Expression—ZFP36—rheumatoid arthritis	0.000102	0.00183	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ZFP36—rheumatoid arthritis	0.000102	0.00183	CbGpPWpGaD
Tazarotene—Rash—Triamcinolone—rheumatoid arthritis	0.000101	0.00155	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000101	0.00155	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	0.000101	0.00183	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	0.000101	0.00183	CbGpPWpGaD
Tazarotene—Rash—Methylprednisolone—rheumatoid arthritis	0.000101	0.00154	CcSEcCtD
Tazarotene—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000101	0.00154	CcSEcCtD
Tazarotene—RARG—Gene Expression—TNFSF13—rheumatoid arthritis	0.0001	0.00181	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MED1—rheumatoid arthritis	9.88e-05	0.00178	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RBPJ—rheumatoid arthritis	9.33e-05	0.00168	CbGpPWpGaD
Tazarotene—Rash—Betamethasone—rheumatoid arthritis	9.21e-05	0.0014	CcSEcCtD
Tazarotene—Rash—Dexamethasone—rheumatoid arthritis	9.21e-05	0.0014	CcSEcCtD
Tazarotene—Dermatitis—Dexamethasone—rheumatoid arthritis	9.2e-05	0.0014	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—rheumatoid arthritis	9.2e-05	0.0014	CcSEcCtD
Tazarotene—Pain—Methotrexate—rheumatoid arthritis	9.09e-05	0.00139	CcSEcCtD
Tazarotene—RARB—Gene Expression—TNFSF13—rheumatoid arthritis	9.01e-05	0.00163	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—VDR—rheumatoid arthritis	9.01e-05	0.00162	CbGpPWpGaD
Tazarotene—Pruritus—Prednisone—rheumatoid arthritis	9e-05	0.00137	CcSEcCtD
Tazarotene—RXRB—Gene Expression—RBPJ—rheumatoid arthritis	8.94e-05	0.00161	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RBPJ—rheumatoid arthritis	8.94e-05	0.00161	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	8.92e-05	0.00161	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MED1—rheumatoid arthritis	8.86e-05	0.0016	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TNFSF13—rheumatoid arthritis	8.64e-05	0.00156	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—TNFSF13—rheumatoid arthritis	8.64e-05	0.00156	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	8.55e-05	0.00154	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MED1—rheumatoid arthritis	8.5e-05	0.00153	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MED1—rheumatoid arthritis	8.5e-05	0.00153	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—rheumatoid arthritis	8.41e-05	0.00152	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—rheumatoid arthritis	8.11e-05	0.00146	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—VDR—rheumatoid arthritis	8.08e-05	0.00146	CbGpPWpGaD
Tazarotene—Rash—Prednisone—rheumatoid arthritis	8.02e-05	0.00122	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—rheumatoid arthritis	8.01e-05	0.00122	CcSEcCtD
Tazarotene—RARA—Adipogenesis—TNF—rheumatoid arthritis	7.85e-05	0.00142	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—VDR—rheumatoid arthritis	7.74e-05	0.0014	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—VDR—rheumatoid arthritis	7.74e-05	0.0014	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	7.74e-05	0.0014	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	7.61e-05	0.00137	CbGpPWpGaD
Tazarotene—Pruritus—Methotrexate—rheumatoid arthritis	7.52e-05	0.00115	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	7.42e-05	0.00134	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	7.38e-05	0.00133	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	7.29e-05	0.00132	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—rheumatoid arthritis	7.27e-05	0.00131	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	7.02e-05	0.00127	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—rheumatoid arthritis	6.97e-05	0.00126	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—rheumatoid arthritis	6.97e-05	0.00126	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	6.74e-05	0.00122	CbGpPWpGaD
Tazarotene—Rash—Methotrexate—rheumatoid arthritis	6.7e-05	0.00102	CcSEcCtD
Tazarotene—Dermatitis—Methotrexate—rheumatoid arthritis	6.7e-05	0.00102	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	6.47e-05	0.00117	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	6.45e-05	0.00116	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—rheumatoid arthritis	6.34e-05	0.00114	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	6.18e-05	0.00112	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	6.02e-05	0.00109	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	5.97e-05	0.00108	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	5.77e-05	0.00104	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—UBE2D1—rheumatoid arthritis	5.68e-05	0.00102	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	5.31e-05	0.000958	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	5.25e-05	0.000946	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—UBE2D1—rheumatoid arthritis	5.09e-05	0.000918	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	5.09e-05	0.000918	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.93e-05	0.000889	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—UBE2D1—rheumatoid arthritis	4.88e-05	0.00088	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—UBE2D1—rheumatoid arthritis	4.88e-05	0.00088	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.35e-05	0.000785	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.35e-05	0.000785	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—VDR—rheumatoid arthritis	4.34e-05	0.000782	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.04e-05	0.00073	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—rheumatoid arthritis	3.9e-05	0.000704	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—VDR—rheumatoid arthritis	3.89e-05	0.000702	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—VDR—rheumatoid arthritis	3.73e-05	0.000673	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—VDR—rheumatoid arthritis	3.73e-05	0.000673	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.55e-05	0.00064	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—rheumatoid arthritis	3.5e-05	0.000632	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—rheumatoid arthritis	3.36e-05	0.000605	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—rheumatoid arthritis	3.36e-05	0.000605	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FADS2—rheumatoid arthritis	3.29e-05	0.000593	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—POMC—rheumatoid arthritis	2.79e-05	0.000503	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.73e-05	0.000493	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLD4—rheumatoid arthritis	2.19e-05	0.000396	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACAN—rheumatoid arthritis	2.12e-05	0.000382	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC25A12—rheumatoid arthritis	1.99e-05	0.000359	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GC—rheumatoid arthritis	1.94e-05	0.00035	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGES—rheumatoid arthritis	1.94e-05	0.00035	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLB1—rheumatoid arthritis	1.8e-05	0.000325	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MED1—rheumatoid arthritis	1.58e-05	0.000285	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—B3GNT2—rheumatoid arthritis	1.47e-05	0.000265	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACP5—rheumatoid arthritis	1.47e-05	0.000265	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BGN—rheumatoid arthritis	1.32e-05	0.000239	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX5—rheumatoid arthritis	1.22e-05	0.00022	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.07e-05	0.000193	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	9.92e-06	0.000179	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	9.76e-06	0.000176	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	8.54e-06	0.000154	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—rheumatoid arthritis	7.14e-06	0.000129	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	5.96e-06	0.000108	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—POMC—rheumatoid arthritis	4.77e-06	8.6e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—rheumatoid arthritis	4.34e-06	7.84e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	4.16e-06	7.5e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	3.8e-06	6.86e-05	CbGpPWpGaD
